Anchoring skeletal muscle development and disease: The role of ankyrin repeat domain containing proteins in muscle physiology

Critical Reviews in Biochemistry and Molecular Biology

Volumn 45, Issue 4, 2010, Pages 318-330

  Tee, Jin Ming ^a   Peppelenbosch, Maikel P ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ankyrin and SOCS box containing protein; Ankyrin repeat; Cell differentiation; Mechanical stress; Muscle metabolism; Notch receptor; Proteinprotein interaction; Transcriptional responses

Indexed keywords

ANKYRIN; NOTCH RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING;

CELL DIFFERENTIATION; HUMAN; MECHANICAL STRESS; MUSCLE DEVELOPMENT; MUSCLE METABOLISM; MUSCULAR DYSTROPHY; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE;

ANIMALS; ANKYRIN REPEAT; HUMANS; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MUSCLE, SKELETAL;

EID: 77954578961     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2010.488217     Document Type: Review

References (112)

1. Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ and Den Dunnen JT. 2006. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confrm the reading-frame rule. Muscle Nerve 34:135-144.
2. Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, Tomaru K, Sekiguchi K, Arai M, Nakamura T and Nagai R. 2000. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 36:48-53.
3. Anderson KM, Berrebi-Bertrand I, Kirkpatrick RB, McQueney MS, Underwood DC, Rouanet S and Chabot-Fletcher M. 1999. cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy. J Mol Cell Cardiol 31:705-719.
4. Ayalon G, Davis JQ, Scotland PB and Bennett V. 2008. An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. Cell 135:1189-1200.
5. Bakay M, Zhao P, Chen J and Hofman EP. 2002. A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 12 Suppl 1:S125-141.
6. Bang ML, Mudry RE, McElhinny AS, Trombitas K, Geach AJ, Yamasaki R, Sorimachi H, Granzier H, Gregorio CC and Labeit S. 2001. Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J Cell Biol 153:413-427.
7. Barash IA, Mathew L, Ryan AF, Chen J and Lieber RL. 2004. Rapid muscle-specifc gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 286:C355-364.
8. Barash IA, Bang ML, Mathew L, Greaser ML, Chen J and Lieber RL. 2007. Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle. Am J Physiol Cell Physiol 293:C218-227.
9. Baumeister A, Arber S and Caroni P. 1997. Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. J Cell Biol 139:1231-1242.
10. Bello NF, Lamsoul I, Heuze ML, Metais A, Moreaux G, Calderwood DA, Duprez D, Moog-Lutz C and Lutz PG. 2009. Te E3 ubiquitin ligase specifcity subunit ASB2beta is a novel regulator of muscle diferentiation that targets flamin B to proteasomal degradation. Cell Death Difer 16:921-932
11. Bennett V. 1978. Purifcation of an active proteolytic fragment of the membrane attachment site for human erythrocyte spectrin. J Biol Chem 253:2292-2299.
12. Bennett V and Baines AJ. 2001. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev 81:1353-1392.
13. Boengler K, Pipp F, Fernandez B, Richter A, Schaper W and Deindl E. 2003. Te ankyrin repeat containing SOCS box protein 5: a novel protein associated with arteriogenesis. Biochem Biophys Res Commun 302:17-22.
14. Borzok MA, Catino DH, Nicholson JD, Kontrogianni-Konstantopoulos A and Bloch RJ. 2007. Mapping the binding site on small ankyrin 1 for obscurin. J Biol Chem 282:32384-32396.
15. Brand-Saberi B and Christ B. 2000. Evolution and development of distinct cell lineages derived from somites. Curr Top Dev Biol 48:1-42.
16. Breeden L and Nasmyth K. 1987. Similarity between cell-cycle genes of budding yeast and fssion yeast and the Notch gene of Drosophila. Nature 329:651-654.
17. Bryson-Richardson RJ and Currie PD. 2008. Te genetics of vertebrate myogenesis. Nat Rev Genet 9:632-646.
18. Cardamone M, Darras BT and Ryan MM. 2008. Inherited myopathies and muscular dystrophies. Semin Neurol 28:250-259.
19. Casey WM, Brodie T, Yoon L, Ni H, Jordan HL and Cariello NF. 2008. Correlation analysis of gene expression and clinical chemistry to identify biomarkers of skeletal myopathy in mice treated with PPAR agonist GW610742X. Biomarkers 13:364-376.
20. Charge SB and Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238.
21. Chen L, Ong B and Bennett V. 2001. LAD-1, the Caenorhabditis elegans L1CAM homologue, participates in embryonic and gonadal morphogenesis and is a substrate for fbroblast growth factor receptor pathway-dependent phosphotyrosine-based signaling. J Cell Biol 154:841-855.
22. Chu W, Burns DK, Swerlick RA and Presky DH. 1995. Identifcation and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J Biol Chem 270:10236-10245.
23. Chung AS, Guan YJ, Yuan ZL, Albina JE and Chin YE. 2005. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol Cell Biol 25:4716-4726.
24. Diks SH, Sartori Da Silva MA, Hillebrands JL, Bink RJ, Versteeg HH, Van Rooijen C, Brouwers A, Chitnis AB, Peppelenbosch MP and Zivkovic D. 2008. d-Asb11 is an essential mediator of canonical Delta-Notch signalling. Nat Cell Biol 10:1190-1198.
25. Fortini ME. 2001. Notch and presenilin: a proteolytic mechanism emerges. Curr Opin Cell Biol 13:627-634.
26. Fortini ME. 2002. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol 3:673-684.
27. Furukawa Y, Hashimoto N, Yamakuni T, Ishida Y, Kato C, Ogashiwa M, Kobayashi M, Kobayashi T, Nonaka I, Mizusawa H and Song SY. 2003. Down-regulation of an ankyrin repeat-containing protein, V-1, during skeletal muscle diferentiation and its re-expression in the regenerative process of muscular dystrophy. Neuromuscul Disord 13:32-41.
28. Gupta S and Sen S. 2002. Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy. Biochim Biophys Acta 1589:247-260.
29. Gupta S, Purcell NH, Lin A and Sen S. 2002. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019-1028.
30. Hashemi SM, Hund TJ and Mohler PJ. 2009. Cardiac ankyrins in health and disease. J Mol Cell Cardiol 47:203-209.
31. Hayashi T, Takeshita K, Tsuchida N, Kitano K, Kawabata S, Iwanaga S and Ito T. 1998. Purifcation of a novel muscle cell growth factor S-myotrophin from porcine skeletal muscle. Int J Biochem Cell Biol 30:897-908.
32. Hayashi T, Ogawa T, Sato M, Tsuchida N, Fotovati A, Iwamoto H, Ikeuchi Y, Cassens RG and Ito T. 2001. S-myotrophin promotes the hypertrophy of myotube as insulin-like growth factor-I does. Int J Biochem Cell Biol 33:831-838.
33. Hentzen ER, Lahey M, Peters D, Mathew L, Barash IA, Friden J and Lieber RL. 2006. Stress-dependent and-independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions in rats. J Physiol 570:157-167.
34. Hirsinger E, Malapert P, Dubrulle J, Delfni MC, Duprez D, Henrique D, Ish-Horowicz D and Pourquie O. 2001. Notch signalling acts in postmitotic avian myogenic cells to control MyoD activation. Development 128:107-116.
35. Hopitzan AA, Baines AJ and Kordeli E. 2006. Molecular evolution of ankyrin: gain of function in vertebrates by acquisition of an obscurin/titin-binding-related domain. Mol Biol Evol 23:46-55.
36. Hunter RB and Kandarian SC. 2004. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 114:1504-1511.
37. Ikeda K, Emoto N, Matsuo M and Yokoyama M. 2003. Molecular iden-tifcation and characterization of a novel nuclear protein whose expression is up-regulated in insulin-resistant animals. J Biol Chem 278:3514-3520.
38. Ishiguro N, Baba T, Ishida T, Takeuchi K, Osaki M, Araki N, Okada E, Takahashi S, Saito M, Watanabe M, Nakada C, Tsukamoto Y, Sato K, Ito K, Fukayama M, Mori S, Ito H and Moriyama M. 2002. Carp, a cardiac ankyrin-repeated protein, and its new homo-logue, Arpp, are diferentially expressed in heart, skeletal muscle, and rhabdomyosarcomas. Am J Pathol 160:1767-1778.
39. Ishiguro N, Motoi T, Osaki M, Araki N, Minamizaki T, Moriyama M, Ito H and Yoshida H. 2005. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in parafn-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomy-osarcoma. Hum Pathol 36:620-625.
40. Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE and Kedes L. 1997. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem 272:22800-22808.
41. Kanai H, Tanaka T, Aihara Y, Takeda S, Kawabata M, Miyazono K, Nagai R and Kurabayashi M. 2001. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ Res 88:30-36.
42. Kemp TJ, Sadusky TJ, Saltisi F, Carey N, Moss J, Yang SY, Sassoon DA, Goldspink G and Coulton GR. 2000. Identifcation of Ankrd2, a novel skeletal muscle gene coding for a stretch-responsive ankyrin-repeat protein. Genomics 66:229-241.
43. Kile BT, Viney EM, Willson TA, Brodnicki TC, Cancilla MR, Herlihy AS, Croker BA, Baca M, Nicola NA, Hilton DJ and Alexander WS. 2000. Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4. Gene 258:31-41.
44. Kile BT, Metcalf D, Mifsud S, Dirago L, Nicola NA, Hilton DJ and Alexander WS. 2001. Functional analysis of Asb-1 using genetic modifcation in mice. Mol Cell Biol 21:6189-6197.
45. Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM and Hilton DJ. 2002. Te SOCS box: a tale of destruction and degradation. Trends Biochem Sci 27:235-241.
46. Kizhatil K, Davis JQ, Davis L, Hofman J, Hogan BL and Bennett V. 2007a. Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J Biol Chem 282:26552-26561.
47. Kizhatil K, Yoon W, Mohler PJ, Davis LH, Hofman JA and Bennett V. 2007b. Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells. J Biol Chem 282:2029-2037.
48. Kizhatil K, Baker SA, Arshavsky VY and Bennett V. 2009a. Ankyrin-G promotes cyclic nucleotide-gated channel transport to rod pho-toreceptor sensory cilia. Science 323:1614-1617.
49. Kizhatil K, Sandhu NK, Peachey NS and Bennett V. 2009b. Ankyrin-B is required for coordinated expression of beta-2-spectrin, the Na/K-ATPase and the Na/Ca exchanger in the inner segment of rod photoreceptors. Exp Eye Res 88:57-64.
50. Knuefermann P, Chen P, Misra A, Shi SP, Abdellatif M and Sivasubramanian N. 2002. Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers. J Biol Chem 277:23888-23897.
51. Knuefermann P, Shi SP, Chen P, Sakata Y, Baumgarten G and Sivasubramanian N. 2006. Myotrophin/V-1 does not act as an extracellular signal to induce myocyte hypertrophy. Tex Heart Inst J 33:281-289.
52. Kojic S, Medeot E, Guccione E, Krmac H, Zara I, Martinelli V, Valle G and Faulkner G. 2004. Te Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J Mol Biol 339:313-325.
53. Kopan R, Nye JS and Weintraub H. 1994. Te intracellular domain of mouse Notch: a constitutively activated repressor of myo-genesis directed at the basic helix-loop-helix region of MyoD. Development 120:2385-2396.
54. Kordeli E, Lambert S and Bennett V. 1995. AnkyrinG. A new ankyrin gene with neural-specifc isoforms localized at the axonal initial segment and node of Ranvier. J Biol Chem 270:2352-2359.
55. Kordeli E, Ludosky MA, Deprette C, Frappier T and Cartaud J. 1998. AnkyrinG is associated with the postsynaptic membrane and the sarcoplasmic reticulum in the skeletal muscle fber. J Cell Sci 111:2197-2207.
56. Kuo H, Chen J, Ruiz-Lozano P, Zou Y, Nemer M and Chien KR. 1999. Control of segmental expression of the cardiac-restricted ankyrin repeat protein gene by distinct regulatory pathways in murine cardiogenesis. Development 126:4223-4234.
57. Lambert S and Bennett V. 1993. Postmitotic expression of ankyrinR and beta R-spectrin in discrete neuronal populations of the rat brain. J Neurosci 13:3725-3735.
58. Li JY, Chai BX, Zhang W, Liu YQ, Ammori JB and Mulholland MW. 2007. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity. Cell Signal 19:1185-1192.
59. Linker C, Lesbros C, Stark MR and Marcelle C. 2003. Intrinsic signals regulate the initial steps of myogenesis in vertebrates. Development 130:4797-4807.
60. Liu Y, Li J, Zhang F, Qin W, Yao G, He X, Xue P, Ge C, Wan D and Gu J. 2003. Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. Biochem Biophys Res Commun 300:972-979.
61. Lux SE, John KM and Bennett V. 1990. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-diferentiation and cell-cycle control proteins. Nature 344:36-42.
62. Lydie L, Laurence S, Carinne R, Nathalie B, Ahmed O, Marc B, Isabelle R and Nathalie D. 2009. Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. FEBS Journal 276:669-684.
63. Marcotte EM, Pellegrini M, Yeates TO and Eisenberg D. 1999. A census of protein repeats. J Mol Biol 293:151-160.
64. McDaneld TG and Spurlock DM. 2008. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters diferentiation of mouse C2C12 myoblasts and phosphor-ylation of mitogen-activated protein kinase and Akt. J Anim Sci 86:2897-2902.
65. McMahon CD, Popovic L, Oldham JM, Jeanplong F, Smith HK, Kambadur R, Sharma M, Maxwell L and Bass JJ. 2003. Myostatin-defcient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285:E82-87.
66. Michaely P and Bennett V. 1992. Te ANK repeat: a ubiquitous motif involved in macromolecular recognition. Trends Cell Biol 2:127-129.
67. Mikhailov AT and Torrado M. 2008. Te enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease. Int J Dev Biol 52:811-821.
68. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC and Labeit S. 2003. Te muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin flament-based stress response molecules. J Mol Biol 333:951-964.
69. Mingozzi F, Meulenberg JJ, Hui DJ, Basner-Tschakarjan E, Hasbrouck NC, Edmonson SA, Hutnick NA, Betts MR, Kastelein JJ, Stroes ES and High KA. 2009. AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specifc T cells. Blood 114:2077-2086.
70. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, Dubell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H and Bennett V. 2003 Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421:634-639.
71. Mohler PJ, Rivolta I, Napolitano C, Lemaillet G, Lambert S, Priori SG and Bennett V. 2004. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci USA 101:17533-17538.
72. Mosavi LK, Williams S and Peng Zy ZY. 2002. Equilibrium folding and stability of myotrophin: a model ankyrin repeat protein. J Mol Biol 320:165-170.
73. Mosavi LK, Cammett TJ, Desrosiers DC and Peng ZY. 2004. Te ankyrin repeat as molecular architecture for protein recognition. Protein Sci 13:1435-1448.
74. Mukherjee DP, McTiernan CF and Sen S. 1993. Myotrophin induces early response genes and enhances cardiac gene expression. Hypertension 21:142-148.
75. Nakada C, Oka A, Nonaka I, Sato K, Mori S, Ito H and Moriyama M. 2003a. Cardiac ankyrin repeat protein is preferentially induced in atrophic myofbers of congenital myopathy and spinal muscular atrophy. Pathol Int 53:653-658.
76. Nakada C, Tsukamoto Y, Oka A, Nonaka I, Takeda S, Sato K, Mori S, Ito H and Moriyama M. 2003b. Cardiac-restricted ankyrin-repeated protein is diferentially induced in duchenne and congenital muscular dystrophy. Lab Invest 83:711-719.
77. Nakamura K, Nakada C, Takeuchi K, Osaki M, Shomori K, Kato S, Ohama E, Sato K, Fukayama M, Mori S, Ito H and Moriyama M. 2002. Altered expression of cardiac ankyrin repeat protein and its homologue, ankyrin repeat protein with PEST and proline-rich region, in atrophic muscles in amyotrophic lateral sclerosis. Pathobiology 70:197-203.
78. O'Brien RJ, Loke I, Davies JE, Squire IB and Ng LL. 2003. Myotrophin in human heart failure. J Am Coll Cardiol 42:719-725.
79. Otto E, Kunimoto M, McLaughlin T and Bennett V. 1991. Isolation and characterization of cDNAs encoding human brain ankyrins reveal a family of alternatively spliced genes. J Cell Biol 114:241-253.
80. Pallavicini A, Kojic S, Bean C, Vainzof M, Salamon M, Ievolella C, Bortoletto G, Pacchioni B, Zatz M, Lanfranchi G, Faulkner G and Valle G. 2001. Characterization of human skeletal muscle Ankrd2. Biochem Biophys Res Commun 285:378-386.
81. Pennica D, Shaw KJ, Luoh SM and Wood WI. 1995. Isolation of cDNA clones encoding the mouse protein V-1. Gene 158:305-306.
82. Peppelenbosch MP, Zivkovic D, Diks S and Bink RJ. 2004. Asb-a tran-scripional repressor proteins and nucleic acids and their aplica-tion in expansion of stem cells (Patent Number WO2004048408).
83. Pescatori M, Broccolini A, Minetti C, Bertini E, Bruno C, D'Amico A, Bernardini C, Mirabella M, Silvestri G, Giglio V, Modoni A, Pedemonte M, Tasca G, Galluzzi G, Mercuri E, Tonali PA and Ricci E. 2007. Gene expression profling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 21:1210-1226.
84. Peters LL, John KM, Lu FM, Eicher EM, Higgins A, Yialamas M, Turtzo LC, Otsuka AJ and Lux SE. 1995. Ank3 (epithelial ankyrin), a widely distributed new member of the ankyrin gene family and the major ankyrin in kidney, is expressed in alternatively spliced forms, including forms that lack the repeat domain. J Cell Biol 130:313-330.
85. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W and Andrade FH. 2002. A chronic infammatory response dominates the skeletal muscle molecular signature in dystrophin-defcient mdx mice. Hum Mol Genet 11:263-272.
86. Rider Jr SD and Zhu G. 2009. An apicomplexan ankyrin-repeat his-tone deacetylase with relatives in photosynthetic eukaryotes. Int J Parasitol 39:747-754.
87. Seale P, Ishibashi J, Holterman C and Rudnicki MA. 2004. Muscle satellite cell-specifc genes identifed by genetic profling of MyoD-defcient myogenic cell. Dev Biol 275:287-300.
88. Sedgwick SG and Smerdon SJ. 1999. Te ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 24:311-316.
89. Sen S, Kundu G, Mekhail N, Castel J, Misono K and Healy B. 1990. Myotrophin: purifcation of a novel peptide from spontaneously hypertensive rat heart that infuences myocardial growth. J Biol Chem 265:16635-16643.
90. Sharma M, Langley B, Bass J and Kambadur R. 2001. Myostatin in muscle growth and repair. Exerc Sport Sci Rev 29:155-158.
91. Sil P, Kandaswamy V and Sen S. 1998. Increased protein kinase C activity in myotrophin-induced myocyte growth. Circ Res 82:1173-1188.
92. Sil P, Misono K and Sen S. 1993. Myotrophin in human cardiomyo-pathic heart. Circ Res 73:98-108.
93. Sivasubramanian N, Adhikary G, Sil PC and Sen S. 1996a. Cardiac myotrophin exhibits rel/NF-kappa B interacting activity in vitro. J Biol Chem 271:2812-2816.
94. Sivasubramanian S, Vijayshankar CS, Krishnamurthy SM, Santhosham R, Dwaraknath V and Rajaram S. 1996b. Surgical management of prosthetic valve obstruction with the Sorin tilting disc prosthesis. J Heart Valve Dis 5:548-552.
95. Stevenson EJ, Giresi PG, Koncarevic A and Kandarian SC. 2003. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551:33-48.
96. Suzuki N, Aoki M, Hinuma Y, Takahashi T, Onodera Y, Ishigaki A, Kato M, Warita H, Tateyama M and Itoyama Y. 2005. Expression profling with progression of dystrophic change in dysferlin-defcient mice (SJL). Neurosci Res 52:47-60.
97. Taoka M, Yamakuni T, Song SY, Yamakawa Y, Seta K, Okuyama T and Isobe T. 1992. A rat cerebellar protein containing the cdc10/SWI6 motif. Eur J Biochem 207:615-620.
98. Taoka M, Isobe T, Okuyama T, Watanabe M, Kondo H, Yamakawa Y, Ozawa F, Hishinuma F, Kubota M, Minegishi A, Song SY, and Yamakuni T. 1994. Murine cerebellar neurons express a novel gene encoding a protein related to cell cycle control and cell fate determination proteins. J Biol Chem 269:9946-9951.
99. Tee J-M. 2010. Cell Fate Determination in Zebrafsh Embryonic and Adult Muscle Development Utrecht: Hubrecht Institute.
100. Tevananther S, Kolli AH and Devarajan P. 1998. Identifcation of a novel ankyrin isoform (AnkG190) in kidney and lung that associates with the plasma membrane and binds alpha-Na, K-ATPase. J Biol Chem 273:23952-23958.
101. Tischler ME. 1994. Efect of the antiglucocorticoid RU38486 on protein metabolism in unweighted soleus muscle. Metabolism 43:1451-1455.
102. Tsukamoto Y, Senda T, Nakano T, Nakada C, Hida T, Ishiguro N, Kondo G, Baba T, Sato K, Osaki M, Mori S, Ito H and Moriyama M. 2002. Arpp, a new homolog of carp, is preferentially expressed in type 1 skeletal muscle fbers and is markedly induced by denerva-tion. Lab Invest 82:645-655.
103. Tsukamoto Y, Hijiya N, Yano S, Yokoyama S, Nakada C, Uchida T, Matsuura K and Moriyama M. 2008. Arpp/Ankrd2, a member of the muscle ankyrin repeat proteins (MARPs), translocates from the I-band to the nucleus after muscle injury. Histochem Cell Biol 129:55-64.
104. Weinmaster G. 2000. Notch signal transduction: a real rip and more. Curr Opin Genet Dev 10:363-369.
105. Willmann R, Possekel S, Dubach-Powell J, Meier T and Ruegg MA. 2009. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord 19:241-249.
106. Wilson-Rawls J, Molkentin JD, Black BL and Olson EN. 1999. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol Cell Biol 19:2853-2862.
107. Witt CC, Ono Y, Puschmann E, McNabb M, Wu Y, Gotthardt M, Witt SH, Haak M, Labeit D, Gregorio CC, Sorimachi H, Granzier H and Labeit S. 2004. Induction and myofbrillar targeting of CARP, and suppression of the Nkx2.5 pathway in the MDM mouse with impaired titin-based signaling. J Mol Biol 336:145-154.
108. Yamakuni T, Hashimoto M, Sakagami H, Yamamoto T, Kobayashi M, Fujii Y, Yamamoto H, Rohra DK, Hiwatashi Y, Honma T, Kondo H, Shido O and Ohizumi Y. 2002. Expression of V-1, a novel catecho-lamine biosynthesis regulatory protein, is enhanced by hypertension in atrial myocytes of Dahl salt-sensitive rats. Biochem Biophys Res Commun 298:793-797.
109. Yang W, Zhang Y, Ma G, Zhao X, Chen Y and Zhu D. 2005. Identifcation of gene expression modifcations in myostatin-stimulated myob-lasts. Biochem Biophys Res Commun 326:660-666.
110. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM and Lee SJ. 2002. Induction of cachexia in mice by systemically administered myostatin. Science 296:1486-1488.
111. Zou Y, Evans S, Chen J, Kuo HC, Harvey RP and Chien KR. 1997. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development 124: 793-804.
112. Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, Hoheisel JD, Zucker IH, Pepe S and Eschenhagen T. 2002. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 293:1377-1382.